Atyr Pharma Inc (ATYR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 33,840 | 16,910 | 47,660 | 37,510 | 22,580 |
| Other Operating Activity | 27,960 | 5,980 | 75,900 | 61,880 | 40,410 |
| Operating Cash Flow | $61,800 | $22,890 | $123,560 | $99,390 | $62,990 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | -62,470 | -59,840 | -386,910 | -353,800 | -205,640 |
| Investing Cash Flow | $-62,470 | $-59,840 | $-386,910 | $-353,800 | $-205,640 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -5,090 | -6,740 | -92,900 | -8,740 | -430 |
| Financing Cash Flow | $-5,090 | $-6,740 | $-92,900 | $-8,740 | $-430 |
| Exchange Rate Effect | 9,000 | 200 | 15,860 | 11,280 | 9,800 |
| Beginning Cash Position | 537,810 | 537,810 | 878,210 | 878,210 | 878,210 |
| End Cash Position | 541,070 | 494,330 | 537,810 | 626,330 | 744,940 |
| Net Cash Flow | $3,250 | $-43,480 | $-340,390 | $-251,870 | $-133,260 |
| Free Cash Flow | |||||
| Operating Cash Flow | 61,800 | 22,890 | 123,560 | 99,390 | 62,990 |
| Free Cash Flow | 61,800 | 22,890 | 123,560 | 99,390 | 62,990 |